This compound is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting various diseases, including bacterial infections and inflammatory conditions. Its unique structure allows for the introduction of difluoromethyl groups, which can enhance the metabolic stability and bioavailability of the final drug molecules. Additionally, it is utilized in research settings for the design and optimization of novel therapeutic agents, contributing to advancements in medicinal chemistry.